Psychiatric and substance abuse comorbidity among HIV seropositive and HIV seronegative prisoners in Malaysia

American Journal of Drug and Alcohol Abuse

Volumn 36, Issue 1, 2010, Pages 31-38

  Zahari, Muhammad Muhsin ^a   Hwan Bae, Woong ^b   Zainal, Nor Zuraida ^a   Habil, Hussain ^a   Kamarulzaman, Adeeba ^a   Altice, Frederick L ^b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Comorbidity; Drug policy; Health care policy; HIV; Malaysia; Mental illness; Prisoners; Southeast Asia; Substance abuse

Indexed keywords

AMPHETAMINE; CANNABIS; OPIATE; SEDATIVE AGENT;

ADULT; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CANNABIS ADDICTION; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DRUG ABUSE; DRUG USE; DYSTHYMIA; ETHNICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALAYSIA; MALE; MARRIAGE; MENTAL DISEASE; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; OPIATE ADDICTION; PANIC; PRISON; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; SERODIAGNOSIS; SEROPREVALENCE; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SUBSTANCE ABUSE; VIOLENCE;

ADULT; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DUAL (PSYCHIATRY); HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; MALAYSIA; MENTAL DISORDERS; PREVALENCE; PRISONERS; PSYCHIATRIC STATUS RATING SCALES; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 76649137269     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990903544828     Document Type: Article

References (47)

1. Teplin LA. The prevalence of severe mental disorder among male urban jail detainees: Comparison with the Epidemiologic Catchment Area Program. Am J Public Health 1990; 80:663-669.
2. Diamond PM, Wang EW, Holzer CE, Thomas C, des Anges C. The prevalence of mental illness in prison. Adm PolicyMent Health 2001; 29:21-40.
3. Spaulding A, Stephenson B, Macalino G, Ruby W, Clarke JG, Flanigan TP. Human immunodeficiency virus in correctional facilities: A review. Clin Infect Dis 2002; 35:305-312.
4. Otto-Salaj LL, Stevenson LY. Influence of psychiatric diagnoses and symptoms on HIV risk behavior in adults with serious mental illness. AIDS Read 2001; 11:197-198.
5. Altice FL, Mostashari F, Selwyn PA, Checko PJ, Singh R, Tanguay S, Blanchette EA. Predictors of HIV infection among newly sentenced male prisoners. J Acquir Immune Defic SyndrHumRetrovirol 1998; 18:444-453.
6. Himelhoch S, McCarthy JF, Ganoczy D, Medoff D, Dixon LB, Blow FC. Understanding associations between serious mental illness and HIV among patients in the VA Health System. Psychiatr Serv 2007; 58:1165-1172.
7. Koutsilieri E, Scheller C, Sopper S, ter Meulen V, Riederer P. The pathogenesis of HIV-induced dementia. Mech Ageing Dev 2002; 123;1047-1053.
8. Kaul M, Lipton SA. Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. J Neuroimmune Pharmacol 2006,1:138-151.
9. Judd F, Komiti A, Chua P, Mijch A, Hoy J, Grech P, et al. Nature of depression in patients with HIV/AIDS. AustNZ J Psychiatry 2005; 39:826-832.
10. Rihs TA, Begley K, Smith DE, Sarangapany J, Callaghan A, Kelly M, et al. Efavirenz and chronic neuropsychiatric symptoms: a cross-sectional case control study. HIV Med 2006; 7:544-548.
11. Teplin LA. Psychiatric and substance abuse disorders among male urban jail detainees. Am J Public Health 1994; 84:290-293.
12. Holmwood C, Marriott M, Humeniuk R. Substance use patterns in newly admitted male and female South Australian prisoners using the WHOASSIST (Alcohol, Smoking and Substance Involvement Screening Test). Int J Prison Health 2008; 4:198-207.
13. Buckley PF, Brown ES. Prevalence and consequences of dual diagnosis. J Clin Psychiatry 2006; 67:e01-e01.
14. Stoskopf CH, Kim YK, Glover SH. Dual diagnosis: HIV and mental illness, a population-based study. Community mental health journal 2001,37:469-479.
15. Piselli M, Elisei S, Murgia N, Quartesan R, Abram KM. Co-occurring psychiatric and substance use disorders among male detainees in Italy. Int J Law Psychiatry 2009; 32:101-107.
16. Baillargeon J, Binswanger IA, Penn JV, Williams BA, Murray OJ. Psychiatric disorders and repeat incarcerations: the revolving prison door. Am J Psychiatry 2009; 166;103-109.
17. Warner TD, Kramer JH. Closing the Revolving Door?: Substance Abuse Treatment as an Alternative to Traditional Sentencing for Drug-Dependent Offenders. Crim Justice Behav 2009; 36:89-109.
18. Mazlan M, Schottenfeld RS, Chawarski MC. New challenges and opportunities in managing substance abuse in Malaysia. Drug Alcohol Rev 2006; 25;473-478.
19. Malaysian Psychiatric Association, Drug Addiction. July 2006. Available at: http://www.psychiatry-malaysia.org/ Accessed September 1, 2009.
20. Walmsley R.World prison population list. 8th edition: International Centre for Prison Studies, King's College London; 2009.
21. Dolan K, Kite B, Black E, Aceijas C, Stimson GV, Reference Group on HIVAP, et al. HIV in prison in low-income and middle-income countries. Lancet Infect Dis 2007; 7:32-41.
22. The United Nation General Assembly Special Session on HIV/AIDS (UNGASS). UNGASS Country Progress Report: Malaysia, Geneva, Switzerland. 2008.
23. Baillargeon J, Ducate S, Pulvino J, Bradshaw P, Murray O, Olvera R. The association of psychiatric disorders and HIV infection in the correctional setting. Ann Epidemiol 2003; 13;606-612.
24. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. 1986,19;517-524.
25. Loewenstein RJ, Sharfstein SS. Neuropsychiatric aspects of acquired immune deficiency syndrome. Int J Psychiatry Med 1983; 13;255-260.
26. Hinkin CH, Castellon SA, Atkinson JH, Goodkin K. Neuropsychiatric aspects of HIV infection among older adults. J Clin Epidemiol 2001; 54 Suppl 1:S44-S52.
27. Sewell DD. Schizophrenia and HIV. Schizophr Bull 1996; 22;465-473.
28. Cournos F, McKinnon K, Meyer-Bahlburg H, Guido JR, Meyer I. HIV risk activity among persons with severe mental illness: preliminary findings. Hosp Community Psychiatry 1993; 44:1104-1106.
29. Volavka J, Convit A, O'Donnell J, Douyon R, Evangelista C, Czobor P. Assessment of risk behaviors for HIV infection among psychiatric inpatients. Hosp Community Psychiatry 1992; 43:482-485.
30. Kelly JA, Murphy DA, Bahr GR, Brasfield TL, Davis DR, Hauth AC, et al. AIDS/HIV risk behavior among the chronic mentally ill. Am J Psychiatry 1992; 149;886-889.
31. Assadi SM, Noroozian M, Pakravannejad M, Yahyazadeh O, Aghayan S, Shariat SV, Fazel S. Psychiatric morbidity among sentenced prisoners: prevalence study in Iran. Br J Psychiatry 2006; 188;159-164.
32. Holzemer WL, Corless IB, Nokes KM, Turner JG, Brown MA, Powell- Cope GM, et al. Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDS 1999; 13;185-197.
33. Ingersoll K. The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care 2004; 16;199-211.
34. Bradizza CM, Stasiewicz PR, Paas ND. Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: a review. Clin Psychol Rev 2006; 26;162-178.
35. Agbahowe SA, Ohaeri JU, Ogunlesi AO, Osahon R. Prevalence of psychiatric morbidity among convicted inmates in a Nigerian prison community. East Afr Med J 1998; 75:19-26.
36. Bulten E, Nijman H, Van Der Staak C. Psychiatric disorders and personality characteristics of prisoners at regular prison wards. Int J Law Psychiatry 2009; 32:115-119.
37. Rounds-Bryant JL, Baker L. Substance dependence and level of treatment need among recently-incarcerated prisoners. Am J Drug Alcohol Abuse 2007; 33:557-561.
38. Choi P, Kavasery R, Desai MM, Govindasamy S, Kamarulzaman A, Altice FL. Prevalence and Correlates of Community Re-Entry Challenges Faced by HIV-Infected Male Prisoners in Malaysia. Int J STD AIDS 2010:In Press.
39. Lukasiewicz M, Blecha L, Falissard B, Neveu X, Benyamina A, Reynaud M, Gasquet I. Dual diagnosis: prevalence, risk factors, and relationship with suicide risk in a nationwide sample of French prisoners. 2009; 33:160-168.
40. Wallace C, Mullen PE, Burgess P. Criminal offending in schizophrenia over a 25-year period marked by deinstitutionalization and increasing prevalence of comorbid substance use disorders. Am J Psychiatry 2004; 161;716-727.
41. Elhaj O YE, Sakai HE. The prevalence of bipolar and comorbid disorders in the Ottowa County Jail. In: the 157th annual meeting of the American Psychiatric Association. New York, NY; May 3, 2004.
42. Douaihy AB, Stowell KR, Kohnen S, Stoklosa JB, Breitbart WS. Psychiatric aspects of comorbid HIV/AIDS and pain, Part 2. AIDS Read 2007; 17;350-352, 357-361.
43. Bruce RD, Altice FL. Clinical Care of the HIV-Infected Drug User. Infect Dis Clin North Am 2007; 21;149-179.
44. Douaihy AB, Stowell KR, Kohnen S, Stoklosa JB, Breitbart WS. Psychiatric aspects of comorbid HIV/AIDS and pain, Part 1. AIDS Read 2007; 17;310-314.
45. Pollack H, Khoshnood K, Altice F. Health care delivery strategies for criminal offenders. J Health Care Finance 1999; 26;63-77.
46. Maru DS, Basu S, Altice FL. HIV control efforts should directly address incarceration. The Lancet Infectious Diseases 2007; 7:568-569.
47. Mellins CA, Havens JF, McDonnell C, Lichtenstein C, Uldall K, Chesney M, et al. Adherence to antiretroviral medications and medical care in HIVinfected adults diagnosed with mental and substance abuse disorders. AIDS Care 2009; 21;168-177.